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INTRODUCTION
Chronic granulomatous disease (CGD) is a rare, primary 
immunodeficiency disorder of phagocytes.[3] It is 
characterized by repeated bacterial and fungal infections 
with excessive inflammation and granuloma formation 
in the skin, liver, lung, gastrointestinal tract, lymph 
nodes, and bone. CGD has an incidence of 1 in 
200,000–250,000 births,[8,9] and is usually diagnosed early 
in infancy by nitroblue‑tetrazolium (NBT) negativity. 
Fungal infections caused by Aspergillus species are an 
important cause of morbidity and mortality in CGD. 
Aspergillus fumigatus accounts for almost 78% of all 
fungal infections, and is second only to Staphylococcus 
aureus, which is the most frequent cause of infection in 
patients with CGD.[9] The most common organs affected 
by Aspergillus in CGD are the lungs; brain abscesses 
secondary to Aspergillus are very rare.
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Abstract
Background: Chronic granulomatous disease (CGD) is an immune disorder that 
affects phagocytes. It is characterized by recurrent or persistent bacterial and 
fungal infections. Reports of tuberculosis (TB) in patients with CGD are rare. In 
developing countries, where TB is endemic, possibility of other chronic infections 
is often overlooked by physicians.
Case Description: We report the case of a 4‑year‑old boy who had recurrent 
respiratory infections and episodes of headache. He was put on antituberculosis 
(ATT) drugs without microbiological or pathological evidence 2 months prior to 
presentation. The child did not improve and was brought to our hospital where 
a computed tomography scan revealed multiple cerebral abscesses. These 
abscesses were excised. The microbiological specimen was determined to 
be positive for Aspergillus fumigatus. His tracheal aspirate was positive for 
Mycobacterium tuberculosis polymerase chain reaction assay. Further work‑up 
confirmed the diagnosis of CGD in the child.
Conclusion: This report describes the course of the patient’s illness in order to 
highlight the challenges associated with the management of these infections. We also 
aim to stress on the importance of pathological diagnosis before starting a therapy.
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Although these patients have an increased susceptibility 
to tuberculosis (TB), reports of TB in CGD are rare.[4,7] 
In developing countries, where TB is endemic, there is 
a tendency among physicians to treat patients without a 
prior microbiological or pathological confirmation of the 
diagnosis. This can lead to a delay in the diagnosis of 
other potentially fatal infections. We describe this case 
not only because the occurrence of cerebral aspergillosis 
and pulmonary TB in CGD is rare but also to highlight 
the merit of obtaining objective evidence before 
embarking on a specific treatment plan.
CASE REPORT
A 4‑year‑old boy was brought to the Emergency 
Department (ED) from a rural area with complaints 
of fever, headache, and weight loss. He was suffering 
from these symptoms for the past 4 months, which 
had worsened in the past week. His brother informed 
that the child had been unwell since infancy with 
several episodes of respiratory infection and has had 
several hospital admissions. Recently, he had started 
complaining of severe persistent diffuse headaches along 
with nausea, vomiting, and anorexia. He also suffered 
from low grade fever intermittently over this period 
of time. Physicians in his locality who had treated him 
with antibiotic courses for chest infections started him 
on antituberculosis (ATT) drugs 2 months back after an 
MRI, which suggested meningeal enhancement and small 
ring enhancing lesions. He had no history of seizures 
or loss of consciousness. One of his brother had passed 
away at the age of 8 years who was considered to suffer 
from disseminated tuberculosis. On examination, the 
child was listless, emaciated, and extremely irritable. He 
had left‑sided weakness in both the upper and lower 
extremities.
An urgent computed tomography (CT) scan of the head 
showed multiple rings enhancing the left parietooccipital 
region, with significant surrounding edema and mass 
effect [Figure 1a]. His white blood cell count was 
17900/uL, with neutrophils 77.4% and lymphocytes 15.7%. 
Hemoglobin was 10.9 and erythrocyte sedimentation 
rate (ESR) was 88 mm/h. We involved pediatric 
physicians and infectious disease specialists to perform 
a neuronavigation‑guided craniotomy for the excision of 
these abscesses along with the walls, which contained 
thick purulent material. Microscopic examination 
revealed granulomas with fugal hyphae [Figure 2a and b]. 
Presence of Aspergillus was further confirmed on culture. 
Postoperatively, he was successfully extubated and shifted 
to the intensive care unit for postoperative monitoring. 
His weakness also improved. Considering his chronic 
cough and repeated chest infections, we obtained a 
tracheal aspirate for examination, which was positive for 
Mycobacterium tuberculosis polymerase chain reaction 
assay. Considering the history, we screened the child 
for immune deficiency disorders. Nitroblue‑tetrazolium 
(NBT) was found to be negative, which established the 
diagnosis of CGD.
Intravenous (IV) voriconazole was commenced at 
6 mg/kg/dose every 12 h for 2–3 days, which was later 
switched to 6 mg/kg/day orally. Five‑drug ATT treatment 
was restarted for the management of pulmonary TB. He was 
also given broad‑spectrum antibiotics. Pneumococcal and 
meningococcal vaccines were administered as prophylaxis, 
and co‑trimoxazole was included in the regimen for the 
prevention of pneumocystis carinii pneumonia.
The child showed slow improvement, however, the 
treatment course was complicated by fever, seizures, and 
hyponatremia. Repeat CT scans did not show residual 
or recurrent abscesses [Figure 1b]. After stabilization 
of the medical condition, he was discharged. About 
10 days after discharge, his family brought him to the 
ED with complaints of drowsiness. CT scan showed 
Figure 2: (a) 10× magnification reveal chronic granulomatous 
inflammation with central neutrophillic debri and multinucleated 
giant cells. (b) Special periodic acid Schiff staining reveal septate 
fungal hyphae; 40× magnification
a bFigure 1: (a) An axial contrast enhanced image of preoperative CT 
brain showing multiple abscesses in the right parietooccipital area. 
(b) A corresponding postoperative image showing no evidence of 
residual. (c) Axial noncontrast enhanced CT scan brain at follow-up 
showing gross hydrocephalus
ba
c
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hydrocephalus [Figure 1c]. A temporary cerebrospinal 
fluid (CSF) diversion was performed, followed by a 
ventriculoperitoneal shunt once the CSF culture was 
reported negative. The child was again discharged 
after stabilization. He died 4 months later at home in 
respiratory distress. The child could not be brought to us, 
and hence no autopsy was performed to determine the 
actual cause of his death.
DISCUSSION
CGD is a congenital disorder of the immune system, 
which is characterized by impaired NADPH oxidase 
activity of the phagocytes. This results in defective 
intracellular killing of catalase‑positive microorganisms, 
and clinically presents as recurrent, severe infections 
usually in early infancy.[5,8] Although mycobacterium 
is catalase positive, the case reports of Mycobacterium 
tuberculosis are very few.
The child in our case presented with brain abscess caused 
by Aspergillus fumigatus with pulmonary TB. Aspergillus 
is a common pathogen in CGD patients, and most 
commonly manifests as pulmonary complications or 
as infections of the chest wall and bones. Neurological 
complications, especially abscesses of the brain, are 
uncommon and are rarely documented.[8] In fact, there 
has been just one report of culture‑proven Aspergillus 
brain abscess in a child with CGD.
Kolb et al. reported the case of a child suffering from 
CGD along with pulmonary TB where Aspergillus brain 
abscess was highly suspected, but was not proven on 
microscopy or fungal culture. Another case was discussed 
by Frank et al. where Aspergillus growth was proven 
in culture and the child was successfully treated with 
itraconazole and interferon.[5,7] In the present case, we 
used voriconazole to treat the patient. The drug has been 
shown to be efficacious against Aspergillus.[2]
Alsultan et al. reviewed literature on intracranial 
abscesses in CGD and found four cases of intracranial 
aspergillosis.[1] A case reported by Pollack et al. differed 
from the current report in having epidural abscess and 
skull osteomyelitis.[6] Three of the four cases reported 
belonged to the pediatric age group whereas only two had 
supratentorial Aspergillus abscesses. All the cases were 
managed surgically, but with different antifungal agents.[1]
This case highlights several issues of medical and surgical 
importance. In endemic areas, where incidence of TB 
is very high, it is a common practice among physicians 
to start patients on ATT drugs on the basis of history, 
examination, and nonspecific blood tests such as ESR. 
This child had several key features in history to suggest 
the possibility of an underlying immune disorder. 
Important hints were not recognized and the diagnosis 
had a significant delay. Another important point to 
note from this case is the need for a close clinical and 
radiological follow‑up because of the high risk of acute 
hydrocephalus that warrants urgent surgical intervention.
CONCLUSION
Coexisting cerbral aspergillosis and pulmonary TB in 
CGD is rare. Surgical excision of abscesses is essential to 
reduce the mass effect as well as to establish a diagnosis. 
However, these patients need prolonged antifungal drugs 
and a close follow‑up because they are at a high risk 
for the development of hydrocephalus and recurrence 
of abscesses. This case also stresses on the fact that no 
treatment should be offered to such patients without a 
definite pathological diagnosis in the form of biopsy or 
culture.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
1. Alsultan A, Williams MS, Lubner S, Goldman FD. Chronic granulomatous 
disease presenting with disseminated intracranial aspergillosis. Pediatr Blood 
Cancer 2006;47:107-10.
2. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, 
Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy 
of invasive aspergillosis. N Engl J Med 2002;347:408-15.
3. Johnston RB Jr. Clinical aspects of chronic granulomatous disease. Curr Opin 
Hematol 2001;8:17-22.
4. Kloss S, Schuster A, Schroten H, Lamprecht J, Wahn V. Control of proven 
pulmonary and suspected CNS aspergillus infection with itraconazole in a 
patient with chronic granulomatous disease. Eur J Pediatr 1991;150:483-5.
5. Lee E, Oh SH, Kwon JW, Kim BJ, Yu J, Park CJ, et al. A case report of chronic 
granulomatous disease presenting with aspergillus pneumonia in a 2-month 
old girl. Korean J Pediatr 2010;53:722-6.
6. Pollack IF, Pang D, Schuit KE. Chronic granulomatous disease with cranial 
fungal osteomyelitis and epidural abscess: Case report. J Neurosurg 
1987;67:132-6.
7. Saulsbury FT. Successful treatment of Aspergillus brain abscess with 
itraconazole and interferon-γ in a patient with chronic granulomatous disease. 
Clin Infect Dis 2001;32:E137-9.
8. Seger R. Chronic granulomatous disease: Recent advances in pathophysiology 
and treatment. Neth J Med 2010;68:334-40.
9. Stasia MJ, Li XJ. Genetics and immunopathology of chronic granulomatous 
disease. Semin Immunopathol 2008;30:209-35.
